Keywords: oxford, biomedica, licenses, tech, merck, uk-based, signed

Oxford BioMedica licenses tech to Merck

Article | 16 February 2004

Print This

UK-based Oxford BioMedica has signed a license agreement for its LentiVector technology with US drug major Merck & Co.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in